User menu

Severe symptomatic hypomagnesaemia induced by the chronic use of proton pump inhibitors: a case report of a patient with Zollinger-Ellison syndrome.

Bibliographic reference Ströker, E ; Leone, L ; Vandeput, Y ; Borbath, I ; Lefebvre, C. Severe symptomatic hypomagnesaemia induced by the chronic use of proton pump inhibitors: a case report of a patient with Zollinger-Ellison syndrome.. In: Acta Clinica Belgica, Vol. 69, no.1, p. 62-65 (2014)
Permanent URL
  1. Herzig Shoshana J., Acid-Suppressive Medication Use and the Risk for Hospital-Acquired Pneumonia, 10.1001/jama.2009.722
  2. Ray S., Delaney M., Muller A. F., Proton pump inhibitors and acute interstitial nephritis, 10.1136/bmj.c4412
  3. Leonard Jennifer, Marshall John K., Moayyedi Paul, Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression, 10.1111/j.1572-0241.2007.01275.x
  4. Faulhaber GA, Arch Intern Med., 170, 1776 (2010)
  5. Epstein Martin, McGrath Shaun, Law Florence, Proton-Pump Inhibitors and Hypomagnesemic Hypoparathyroidism, 10.1056/nejmc066308
  6. Hess M. W., Hoenderop J. G. J., Bindels R. J. M., Drenth J. P. H., Systematic review: hypomagnesaemia induced by proton pump inhibition, 10.1111/j.1365-2036.2012.05201.x
  7. Sedehizadeh Saam, Keogh Michael, Wills Adrian J., Reversible Hypomagnesaemia-Induced Subacute Cerebellar Syndrome, 10.1007/s12011-010-8757-3
  8. Reffelmann Thorsten, Ittermann Till, Dörr Marcus, Völzke Henry, Reinthaler Markus, Petersmann Astrid, Felix Stephan B., Low serum magnesium concentrations predict cardiovascular and all-cause mortality, 10.1016/j.atherosclerosis.2011.05.038
  9. Sontia Bruno, Touyz Rhian M., Role of magnesium in hypertension, 10.1016/
  10. Reffelmann Thorsten, Dörr Marcus, Ittermann Till, Schwahn Christian, Völzke Henry, Ruppert Jörg, Robinson Daniel, Felix Stephan B., Low serum magnesium concentrations predict increase in left ventricular mass over 5 years independently of common cardiovascular risk factors, 10.1016/j.atherosclerosis.2010.08.073
  11. Barbagallo M, Magnes Res., 23, 131 (2010)
  12. Barbagallo Mario, Dominguez Ligia J., Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance, 10.1016/
  13. Huang C.-L., Kuo E., Mechanism of Hypokalemia in Magnesium Deficiency, 10.1681/asn.2007070792
  14. Schlingmann Karl P., Waldegger Siegfried, Konrad Martin, Chubanov Vladimir, Gudermann Thomas, TRPM6 and TRPM7—Gatekeepers of human magnesium metabolism, 10.1016/j.bbadis.2007.03.009
  15. Bai Jane P. F., Hausman Ethan, Lionberger Robert, Zhang Xinyuan, Modeling and Simulation of the Effect of Proton Pump Inhibitors on Magnesium Homeostasis. 1. Oral Absorption of Magnesium, 10.1021/mp300323q
  16. Schlingmann Karl P., Weber Stefanie, Peters Melanie, Niemann Nejsum Lene, Vitzthum Helga, Klingel Karin, Kratz Markus, Haddad Elie, Ristoff Ellinor, Dinour Dganit, Syrrou Maria, Nielsen Søren, Sassen Martin, Waldegger Siegfried, Seyberth Hannsjörg W., Konrad Martin, Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family, 10.1038/ng889
  17. Fernández-Fernández Francisco José, Sesma Pascual, Caínzos-Romero Tamara, Ferreira Lucía, Hipomagnesemia asociada a tratamiento con omeprazol y test genético negativo para mutación en TRPM6, 10.1016/j.medcli.2010.07.015
  18. Thongon Narongrit, Omeprazole decreases magnesium transport across Caco-2 monolayers, 10.3748/wjg.v17.i12.1574
  19. Danziger John, William Jeffrey H., Scott Daniel J., Lee Joon, Lehman Li-wei, Mark Roger G., Howell Michael D., Celi Leo A., Mukamal Kenneth J., Proton-pump inhibitor use is associated with low serum magnesium concentrations, 10.1038/ki.2012.452